Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides.
Lavigne
Carole
C
Institut de Recherche Medicale Beausejour, Moncton, New Brunswick, Canada.
Lunardi-Iskandar
Yanto
Y
Lebleu
Bernard
B
Thierry
Alain R
AR
D000163:Acquired Immunodeficiency Syndrome; D000818:Animals; D001483:Base Sequence; D002412:Cations; D002460:Cell Line; D045744:Cell Line, Tumor; D003114:Colony-Forming Units Assay / Q000379:methods; D020285:Cryoelectron Microscopy; D004337:Drug Carriers; D004355:Drug Stability; D006367:HeLa Cells; D006801:Humans; D007202:Indicators and Reagents; D008081:Liposomes / Q000138:chemical synthesis* / Q000737:chemistry; D051379:Mice; D008819:Mice, Nude; D018613:Microscopy, Confocal / Q000379:methods; D020319:Oligodeoxyribonucleotides, Antisense / Q000737:chemistry / Q000493:pharmacokinetics*; D009841:Oligonucleotides / Q000493:pharmacokinetics*; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014183:Transplantation, Heterologous; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
D002412:Cations; D004337:Drug Carriers; D007202:Indicators and Reagents; D008081:Liposomes; D020319:Oligodeoxyribonucleotides, Antisense; D009841:Oligonucleotides; D042461:Vascular Endothelial Growth Factor A